Topics
Sector
Geography
Subject

Videos Library

Europe's MDR and proposed pan-European HTA process for reimbursement

Related topics:

This free video is available for registered users

Overview

While evidence requirements have changed under the new European framework for CE arking, the movement towards pan-European Health Technology Assessment also has gained traction, prompting greater conformity of HTA evidence requirements and "transplantation" of evidence reviews across geographies within the European Union.  Companies can expect CE Mark requirements to be more aligned with the demands of HTA bodies for reimbursement, but the challenges for medical device firms are greater, as local HTA bodies may be commissioned to implement assessments that have a pan-European impact. 

Speaker

Stephen Hull
Principal and Founder
Hull Associates, USA

Photo

Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.

REMINDER

This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.

Sponsor

Related Upcoming Events: